These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Endothelin in chronic proteinuric kidney disease. Gagliardini E, Buelli S, Benigni A. Contrib Nephrol; 2011; 172():171-184. PubMed ID: 21893998 [Abstract] [Full Text] [Related]
6. Endothelin antagonism in patients with nondiabetic chronic kidney disease. Dhaun N, Goddard J, Webb DJ. Contrib Nephrol; 2011; 172():243-254. PubMed ID: 21894004 [Abstract] [Full Text] [Related]
7. The endothelin system and its antagonism in chronic kidney disease. Dhaun N, Goddard J, Webb DJ. J Am Soc Nephrol; 2006 Apr; 17(4):943-55. PubMed ID: 16540557 [Abstract] [Full Text] [Related]
8. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence. Neuhofer W, Pittrow D. Eur J Clin Invest; 2009 Jun; 39 Suppl 2():50-67. PubMed ID: 19335747 [Abstract] [Full Text] [Related]
9. Renal function and blood pressure: molecular insights into the biology of endothelin-1. Vignon-Zellweger N, Heiden S, Emoto N. Contrib Nephrol; 2011 Jun; 172():18-34. PubMed ID: 21893986 [Abstract] [Full Text] [Related]
17. Renoprotective effects of ET(A) receptor antagonists therapy in experimental non-diabetic chronic kidney disease: Is there still hope for the future? Vaněčková I, Hojná S, Kadlecová M, Vernerová Z, Kopkan L, Červenka L, Zicha J. Physiol Res; 2018 Jun 27; 67(Suppl 1):S55-S67. PubMed ID: 29947528 [Abstract] [Full Text] [Related]